糖尿病作为认知功能障碍的独立危险因素,日益受到人们的关注。胰岛素抵抗是2型糖尿病的主要发病机制,与认知功能障碍有着密不可分的关系。作者就胰岛素抵抗与2型糖尿病认知功能障碍的研究进展做一综述。

[1] RAJAGOPAL G,REDDY A P,VENKATA-HARINARAYAN C,et al.Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome[J]. Metab Syndr Relat Disord,2012,10:273-279.
[2] HUANG C C,LEE C C,HSU K S.The role of insulin receptor signaling in synaptic plasticity and cognitive function[J].Chang Gung Med,2010,33(2):115-125.
[3] 郭晓珍, 俞海燕, 施广德.正常高值血压的2型糖尿病患者脉压与颈动脉硬化的关系[J].现代医学,2010,38(5):491-494.
[4] 马学毅.糖尿病的诊断与分类[J].人民军医,1997,40(14):341-342.
[5] NEUMANN K F, ROJO L, NAVARRETE L P,et al. Insulin resistance and Alzheimers disease:molecular links & clinical implications[J].Curr Alzheimer Res,2008,5(5):438-447.
[6] RULIFSON E J, KIM S K, NUSSE R. Ablation of insulin-producing neurons in flies:growth and diabetic phenotypes[J].Science,2002,296:1118-1120.
[7] 杨利英. 高血压合并 2 型糖尿病中老年患者颈动脉更易发生粥样硬化[J].东南大学学报:医学版,2010,29(6):654-657.
[8] FLORANT G L, SINGER L, SCHEURINK A J. Intraventricular insulin reduces food intake and body weight of marmots during the summer feeding period[J].Physiol Behav,1991,49:335-338.
[9] SCHERER T, OHARE J, DIGGS-ANDREWS K,et al.Brain insulin controls adipose tissue lipolysis and lipogenesis[J]. Cell Metab,2011,13:1831-1894.
[10] STRACHAN M W, DEARY I J, EWING F M,et al.Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies[J].Diabetes Care,1997,20:438-445.
[11] SCHRIJVERS E M,WITTEMAN J C,SIJBRANDS E J,et al.Insulin metabolism and the risk of Alzheimer disease:the Rotterdam Study[J].Neurology,2010,75:1982-1987.
[12] LUCHSINGER J A, TANG M X, SHEA S,et al. Hyperinsulinemia and risk of Alzheimer disease[J].Neurology, 2004,63:1187-1192.
[13] JONES A,KULOZIK P,OSTERTAG A,et al.Common pathological processes and transcriptional pathways in Alzheimers disease and type 2 diabetes[J].J Alzheimers Dis,2009,16:787-808.
[14] FRIEDRICH N, JORGENSEN T, JUUL A,et al. Insulin-like growth factor I and anthropometric parameters in a Danish population[J].Exp Clin Endocrinol Diabetes,2012,120:171-174.
[15] STEEN E, TERRY B M, RIVERA E J,et al.Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimers disease-is this type 3 diabetes?[J].Alzheimers Dis,2005,7:63-80.
[16] FROLICH L, BLUM-DEGEN D, BERNSTEIN H G,et al. Brain insulin and insulin receptors in aging and sporadic Alzheimers disease[J].J Neural Transm,1998,105:423-438.
[17] BOSCO D, FAVA A, PLASTINO M, et al. Possible implications of insulin resistance and glucose metabolism in Alzheimers disease pathogenesis[J].Cell Mol Med,2011,15:1807-1821.
[18] TALBOT K, WANG H Y, KAZI H,et al. Demonstrated brain insulin resistance in Alzheimers disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline[J].Clin Invest,2012,122:1316-1338.
[19] JIMENEZ-PALOMARES M, RAMOS-RODRIGUEZ J J, LOPEZ-ACOSTA J F,et al. Increased Abeta production prompts the onset of glucose intolerance and insulin resistance[J].Am J Physiol Endocrinol Metab,2012,302:E1373-1380.
[20] GASPARINI L, GOURAS G K, WANG R,et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling[J].Neurosci,2001,21:2561-2570.
[21] ZHANG H, GAO Y, DAI Z,et al. IGF-1 reduces BACE-1 expression in PC12 cells via activation of PI3-K/Akt and MAPK/ERK1/2 signaling pathways[J].Neurochem Res,2011,36:49-57.
[22] QIU W Q, FOLSTEIN M F.Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimers disease:review and hypothesis[J].Neurobiol Aging,2006,27:190-198.
[23] KILGER E, BUEHLER A, WOELFING H,et al. BRI2 protein regulates beta-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE)[J].Biol Chem,2011,286:37446-37457.
[24] ZHAO W Q, de FELICE F G, FERNANDEZ S,et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors[J].FASEB J,2008,22:246-260.
[25] XIE L, HELMERHORST E, TADDEI K,et al.Alzheimers beta-amyloid peptides compete for insulin binding to the insulin receptor[J].Neurosci,2002,22:1-5.
[26] MACCIONI R B, FARIAS G, MORALES I,et al.The revitalized tau hypothesis on Alzheimers disease[J].Arch Med Res,2010,41:226-231.
[27] PRITCHARD S M,DOLAN P J,VITKUS A,et al. The toxicity of tau in Alzheimer disease:turnover, targets and potential therapeutics[J].Cell Mol Med,2011,15:1621-1635.
[28] de la MONTE S M.Insulin resistance and Alzheimers disease[J].BMB Rep,2009,42:475-481.
[29] CASPERSEN C, WANG N, YAO J,et al.Mitochondrial Abeta:a potential focal point for neuronal metabolic dysfunction in Alzheimers disease[J].FASEB J,2005,19:2040-2041.
[30] SHEN C, CHEN Y, LIU H,et al.Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase[J].Biol Chem,2008,283:17721-17730.
[31] TANSEY M G, MCCOY M K, FRANK-CANNON T C. Neuroinflammatory mechanisms in Parkinsons disease:potential environmental triggers, pathways, and targets for early therapeutic intervention[J].Exp Neurol,2007,208:1-25.
[32] CHOI K, KIM Y B. Molecular mechanism of insulin resistance in obesity and type 2 diabetes[J]. Korean Intern Med,2010,25:119-129.